Europe Lung Cancer Therapy Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Lung Cancer Therapy Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Lung Cancer Therapy Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Cases of Lung Cancer
5.1.2 Government Initiatives for Screening and Treatment of Lung Cancer

5.2 Market Opportunities

5.2.1 Rising Number of Lung Cancer Therapy in Clinical Trials

5.3 Future Trends

5.3.1 Growing Demand for Targeted Therapy

5.4 Impact of Drivers and Restraints

6. Europe Lung Cancer Therapy Market Regional Analysis

6.1 Europe Lung Cancer Therapy Market Overview

6.2 Europe Lung Cancer Therapy Market Revenue 2020-2030 (US$ Million)

6.3 Europe Lung Cancer Therapy Market Forecast Analysis

7. Europe Lung Cancer Therapy Market Analysis – by Therapy Type

7.1 Noninvasive and Minimally Invasive

7.1.1 Overview
7.1.2 Noninvasive and Minimally Invasive: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Lung Cancer Therapy Market Analysis – by Indication

8.1 Non-Small Cell Lung Cancer and Small Cell Lung Cancer

8.1.1 Overview
8.1.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Lung Cancer Therapy Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Oncology Clinics

9.2.1 Overview
9.2.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Research Centers

9.3.1 Overview
9.3.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Lung Cancer Therapy Market – Europe Analysis

10.1 Europe

10.1.1 Europe Lung Cancer Therapy Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Lung Cancer Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.1.2 UK: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.1.3 UK: Europe Lung Cancer Therapy Market Breakdown, by End User

10.1.1.2 Germany: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.2.2 Germany: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.2.3 Germany: Europe Lung Cancer Therapy Market Breakdown, by End User

10.1.1.3 France: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.3.2 France: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.3.3 France: Europe Lung Cancer Therapy Market Breakdown, by End User

10.1.1.4 Russia: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.4.2 Russia: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.4.3 Russia: Europe Lung Cancer Therapy Market Breakdown, by End User

10.1.1.5 Italy: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.5.2 Italy: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.5.3 Italy: Europe Lung Cancer Therapy Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Lung Cancer Therapy Market Breakdown, by Therapy Type
10.1.1.6.2 Rest of Europe: Europe Lung Cancer Therapy Market Breakdown, by Indication
10.1.1.6.3 Rest of Europe: Europe Lung Cancer Therapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Lung Cancer Therapy Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Advanz Pharma Corp

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bioventus Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnson & Johnson

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Medtronic Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Meiji Seika Pharma Co Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Olympus Corp

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 RF Medical Co Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sun Pharmaceutical Industries Ltd

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights